Need for new vaccine formulations and potential of particulate antigen and DNA delivery systems.
about
The Use of Synthetic Carriers in Malaria Vaccine DesignAntibody response to polyhistidine-tagged peptide and protein antigens attached to liposomes via lipid-linked nitrilotriacetic acid in mice.Classification and characterization of therapeutic antibody aggregates.Archaeosomes made of Halorubrum tebenquichense total polar lipids: a new source of adjuvancy.A polymer/oil based nanovaccine as a single-dose immunization approach.Particulate delivery systems for vaccines: what can we expect?The performance of nanocarriers for transmucosal drug delivery.Design opportunities for actively targeted nanoparticle vaccines.Polymer nanoparticles for cross-presentation of exogenous antigens and enhanced cytotoxic T-lymphocyte immune response.Nanoparticles for transcutaneous vaccination.Galactosylated LDL nanoparticles: a novel targeting delivery system to deliver antigen to macrophages and enhance antigen specific T cell responses.Liposomes as delivery systems for nasal vaccination: strategies and outcomes.Topical and mucosal liposomes for vaccine delivery.Self-encapsulating Poly(lactic-co-glycolic acid) (PLGA) Microspheres for Intranasal Vaccine Delivery.Development of thermostable lyophilized inactivated polio vaccine.Trimethyl Chitosan Nanoparticles Encapsulated Protective Antigen Protects the Mice Against Anthrax.The delivery site of a monovalent influenza vaccine within the respiratory tract impacts on the immune response
P2860
Q26777053-898103DD-AFFD-4402-BBC6-B3809583FDB4Q30397437-85ECFD13-2ABE-4699-B1AC-8D5EBD510102Q30502491-15A65260-C663-4AAD-B493-34B5F2A04B37Q33493219-5ECA20B2-0A78-4A72-8B9E-4087EB961B4EQ34685874-11AF842F-1684-45B7-AEED-2238A9291EBDQ36492598-BA868037-5E18-4464-AAD3-D8995FAC7C0FQ36527739-AD76B129-59D0-4306-849E-DB702C0EF0A9Q37062606-6B80B277-838C-4309-9BFA-91C49BBE84C7Q37167802-6C17D99A-0CE5-4F8D-AD4D-081C645E2C92Q37274692-8D00347F-421A-4BFB-B59C-774A191332EBQ37436554-FD65172E-E3DB-450C-9C40-09BF63F882FBQ37748791-3B100FE5-ACC3-4F81-B0AD-C3545D431E7DQ37848296-0DB64EFB-E0E5-4091-8D6C-1A2EBA57C507Q38400992-B496D110-B9A9-469C-9002-FA31A01F6845Q42222649-E031B539-C4A8-4462-877E-43CB99E3E463Q52608524-E6945873-3CB9-45EC-B06A-B9E0E089B5A6Q56994857-BF74CF16-1954-4609-A605-9EA92C75A10C
P2860
Need for new vaccine formulations and potential of particulate antigen and DNA delivery systems.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Need for new vaccine formulati ...... igen and DNA delivery systems.
@ast
Need for new vaccine formulati ...... igen and DNA delivery systems.
@en
type
label
Need for new vaccine formulati ...... igen and DNA delivery systems.
@ast
Need for new vaccine formulati ...... igen and DNA delivery systems.
@en
prefLabel
Need for new vaccine formulati ...... igen and DNA delivery systems.
@ast
Need for new vaccine formulati ...... igen and DNA delivery systems.
@en
P1476
Need for new vaccine formulati ...... igen and DNA delivery systems.
@en
P2093
P304
P356
10.1016/J.ADDR.2004.10.001
P407
P577
2005-01-01T00:00:00Z